Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Mason

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
BMC Health Services Research|January 13, 2011
The social value of a QALY: raising the bar or barring the raise?Cam Donaldson, Rachel Baker, Helen Mason, et al.
Plos One|January 11, 2014
A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countriesHelen Mason, Azza Shoaibi, Rula Ghandour, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2024
Cost-Effectiveness of 2 Models of Pessary Care for Pelvic Organ Prolapse: Findings From the TOPSY Randomized Controlled TrialSarkis Manoukian, Helen Mason, Suzanne Hagen, et al.
Clinical Endocrinology|December 17, 2010
PCOS Forum: research in polycystic ovary syndrome today and tomorrowRenato Pasquali, Elisabet Stener-Victorin, Bulent O Yildiz, et al.
BMJ Open|February 20, 2014
CRIB--the use of cardiac rehabilitation services to aid the recovery of patients with bowel cancer: a pilot randomised controlled trial (RCT) with embedded feasibility studyJulie Munro, Richard Adams, Anna Campbell, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
beta-alanine dipeptides as MC4R agonistsRéjean Ruel, Timothy F Herpin, Lawrence Iben, et al.
Journal of Medicinal Chemistry|February 7, 2003
Substituted pyrazolopyridopyridazines as orally bioavailable potent and selective PDE5 inhibitors: potential agents for treatment of erectile dysfunctionGuixue Yu, Helen Mason, Ximao Wu, et al.
Human Reproduction Update|January 17, 2014
The physiology and clinical utility of anti-Mullerian hormone in womenDidier Dewailly, Claus Yding Andersen, Adam Balen, et al.
Health Technology Assessment (Winchester, England)|February 12, 2024
Strategies used for childhood chronic functional constipation: the SUCCESS evidence synthesisAlex Todhunter-Brown, Lorna Booth, Pauline Campbell, et al.
Trials|October 9, 2020
The TOPSY pessary self-management intervention for pelvic organ prolapse: a study protocol for the process evaluationCarol Bugge, Rohna Kearney, Melanie Dembinsky, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
BMC Health Services Research|January 13, 2011
The social value of a QALY: raising the bar or barring the raise?Cam Donaldson, Rachel Baker, Helen Mason, et al.
Plos One|January 11, 2014
A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countriesHelen Mason, Azza Shoaibi, Rula Ghandour, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2024
Cost-Effectiveness of 2 Models of Pessary Care for Pelvic Organ Prolapse: Findings From the TOPSY Randomized Controlled TrialSarkis Manoukian, Helen Mason, Suzanne Hagen, et al.
Clinical Endocrinology|December 17, 2010
PCOS Forum: research in polycystic ovary syndrome today and tomorrowRenato Pasquali, Elisabet Stener-Victorin, Bulent O Yildiz, et al.
BMJ Open|February 20, 2014
CRIB--the use of cardiac rehabilitation services to aid the recovery of patients with bowel cancer: a pilot randomised controlled trial (RCT) with embedded feasibility studyJulie Munro, Richard Adams, Anna Campbell, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
beta-alanine dipeptides as MC4R agonistsRéjean Ruel, Timothy F Herpin, Lawrence Iben, et al.
Journal of Medicinal Chemistry|February 7, 2003
Substituted pyrazolopyridopyridazines as orally bioavailable potent and selective PDE5 inhibitors: potential agents for treatment of erectile dysfunctionGuixue Yu, Helen Mason, Ximao Wu, et al.
Human Reproduction Update|January 17, 2014
The physiology and clinical utility of anti-Mullerian hormone in womenDidier Dewailly, Claus Yding Andersen, Adam Balen, et al.
Health Technology Assessment (Winchester, England)|February 12, 2024
Strategies used for childhood chronic functional constipation: the SUCCESS evidence synthesisAlex Todhunter-Brown, Lorna Booth, Pauline Campbell, et al.
Trials|October 9, 2020
The TOPSY pessary self-management intervention for pelvic organ prolapse: a study protocol for the process evaluationCarol Bugge, Rohna Kearney, Melanie Dembinsky, et al.
Pageof 8